BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 10814283)

  • 1. Enantioselective synthesis of the [6,6] spiroketal core of reveromycin A.
    Drouet KE; Ling T; Tran HV; Theodorakis EA
    Org Lett; 2000 Jan; 2(2):207-10. PubMed ID: 10814283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Total synthesis of (-)-reveromycin B.
    Cuzzupe AN; Hutton CA; Lilly MJ; Mann RK; Rizzacasa MA; Zammit SC
    Org Lett; 2000 Jan; 2(2):191-4. PubMed ID: 10814279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Total synthesis of reveromycin A.
    Shimizu T; Masuda T; Hiramoto K; Nakata T
    Org Lett; 2000 Jul; 2(14):2153-6. PubMed ID: 10891254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Total synthesis of the epidermal growth factor inhibitor (-)-reveromycin B.
    Cuzzupe AN; Hutton CA; Lilly MJ; Mann RK; McRae KJ; Zammit SC; Rizzacasa MA
    J Org Chem; 2001 Apr; 66(7):2382-93. PubMed ID: 11281779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short synthesis of the 6,6-spiroketal cores of spirofungins A and B.
    Dias LC; de Oliveira LG
    Org Lett; 2004 Jul; 6(15):2587-90. PubMed ID: 15255697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Total synthesis of (-)-reveromycin a.
    El Sous M; Ganame D; Tregloan PA; Rizzacasa MA
    Org Lett; 2004 Aug; 6(17):3001-4. PubMed ID: 15330668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stereoselective total synthesis of reveromycin B and C19-epi-reveromycin B.
    Drouet KE; Theodorakis EA
    Chemistry; 2000 Jun; 6(11):1987-2001. PubMed ID: 10894398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stereoselective total synthesis of (-)-spirofungin A by utilising hydrogen-bond controlled spiroketalisation.
    Lynch JE; Zanatta SD; White JM; Rizzacasa MA
    Chemistry; 2011 Jan; 17(1):297-304. PubMed ID: 21207625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reveromycin A, a new antibiotic which inhibits the mitogenic activity of epidermal growth factor.
    Osada H; Koshino H; Isono K; Takahashi H; Kawanishi G
    J Antibiot (Tokyo); 1991 Feb; 44(2):259-61. PubMed ID: 2010365
    [No Abstract]   [Full Text] [Related]  

  • 10. Synthesis and biological activities of reveromycin A and spirofungin A derivatives.
    Shimizu T; Usui T; Fujikura M; Kawatani M; Satoh T; Machida K; Kanoh N; Woo JT; Osada H; Sodeoka M
    Bioorg Med Chem Lett; 2008 Jul; 18(13):3756-60. PubMed ID: 18519164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Asymmetric total synthesis of (-)-spirofungin A and (+)-spirofungin B.
    Shimizu T; Satoh T; Murakoshi K; Sodeoka M
    Org Lett; 2005 Dec; 7(25):5573-6. PubMed ID: 16320994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enantioselective synthesis of spliceostatin E and evaluation of biological activity.
    Ghosh AK; Veitschegger AM; Sheri VR; Effenberger KA; Prichard BE; Jurica MS
    Org Lett; 2014 Dec; 16(23):6200-3. PubMed ID: 25423085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enantioselective Synthesis of a Cyclopropane Derivative of Spliceostatin A and Evaluation of Bioactivity.
    Ghosh AK; Reddy GC; Kovela S; Relitti N; Urabe VK; Prichard BE; Jurica MS
    Org Lett; 2018 Nov; 20(22):7293-7297. PubMed ID: 30394756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of the C1-C21 domain of azaspiracids-1 and -3.
    Zhang Z; Ding Y; Xu J; Chen Y; Forsyth CJ
    Org Lett; 2013 May; 15(10):2338-41. PubMed ID: 23627769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and stereochemistry of the terminal spiroketal domain of the phosphatase inhibitor dinophysistoxin-2.
    Forsyth CJ; Wang C
    Bioorg Med Chem Lett; 2008 May; 18(10):3043-6. PubMed ID: 18226903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reveromycins revealed: new polyketide spiroketals from Australian marine-derived and terrestrial Streptomyces spp. A case of natural products vs. artifacts.
    Fremlin L; Farrugia M; Piggott AM; Khalil Z; Lacey E; Capon RJ
    Org Biomol Chem; 2011 Feb; 9(4):1201-11. PubMed ID: 21152660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure and absolute stereochemistry of the anticancer agent EBC-23 from the Australian rainforest.
    Dong L; Gordon VA; Grange RL; Johns J; Parsons PG; Porzelle A; Reddell P; Schill H; Williams CM
    J Am Chem Soc; 2008 Nov; 130(46):15262-3. PubMed ID: 18950180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reveromycins, new inhibitors of eukaryotic cell growth. III. Structures of reveromycins A, B, C and D.
    Koshino H; Takahashi H; Osada H; Isono K
    J Antibiot (Tokyo); 1992 Sep; 45(9):1420-7. PubMed ID: 1429227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cephalostatin analogues--synthesis and biological activity.
    Flessner T; Jautelat R; Scholz U; Winterfeldt E
    Fortschr Chem Org Naturst; 2004; 87():1-80. PubMed ID: 15079895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Convergent approach to complex spirocyclic pyrans: practical synthesis of the oxa-pinnaic acid core.
    Ferrari FD; Pasqua AE; Ledgard AJ; Marquez R
    Org Biomol Chem; 2013 Jun; 11(21):3469-76. PubMed ID: 23589153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.